Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry

OBJECTIVES: The CytoSorb therapy in COVID-19 (CTC) registry evaluated the clinical performance and treatment parameters of extracorporeal hemoadsorption integrated with veno-venous extracorporeal membrane oxygenation (VV ECMO) in critically ill COVID-19 patients with acute respiratory distress syndr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayanga, J. W. Awori, Song, Tae, Durham, Lucian, Garrison, Lawrence, Smith, Deane, Molnar, Zsolt, Scheier, Joerg, Deliargyris, Efthymios N., Moazami, Nader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280833/
https://www.ncbi.nlm.nih.gov/pubmed/37337243
http://dx.doi.org/10.1186/s13054-023-04517-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280833/
https://www.ncbi.nlm.nih.gov/pubmed/37337243
http://dx.doi.org/10.1186/s13054-023-04517-3

Ejemplares similares